Return to search results.
Complete title: RTOG 0834: Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1P/19Q Deleted Anaplastic Glioma: The CATNON Intergroup Trial
|Research Study Number||7880|
|Principal Investigator||George Laramore, MD, PhD|
Research Study Description
PURPOSE: This randomized phase III trial is studying giving temozolomide during and/or after radiation therapy to see how well it works compared to radiation therapy alone in treating patients with anaplastic glioma.
Eligibility Criteria (must meet the following to participate in this study)
Other eligibility criteria may apply.
Brain Cancer; Central Nervous System (CNS); Solid Tumors; Neoplasms; Astrocytoma
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.